{"mainPropery":{"diseaseId":7468,"diseaseName":"Progressive multifocal leukoencephalopathy","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/7468/progressive-multifocal-leukoencephalopathy","synonyms":["Leukoencephalopathy, progressive multifocal","PML"],"synonyms-with-source":[{"name":"Leukoencephalopathy, progressive multifocal"},{"name":"PML"}],"identifiers":[]},"diseaseCategories":[{"diseaseTypeId":25,"diseaseTypeName":"Viral infections"}],"organizations":[{"resourceID":2832,"resourceName":"PML Consortium","abbreviation":"","address1":"","address2":"","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"","phone":"","tty":"","tollFree":"","fax":"","email":"","url":"http://pmlconsortium.org","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=PureSearch&db=pubmed&details_term=%28Progressive%5BTitle%5D%20AND%20multifocal%5BTitle%5D%20AND%20leukoencephalopathy%5BTitle%5D%29%20AND%20%22loattrfree%20full%20text%22%5Bsb%5D%20AND%20%222004/01/19%2012.59%22%5BPDAT%5D%20%3A%20%222007/01/19%2012.59%22%5BPDAT%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Progressive multifocal leukoencephalopathy. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Progressive+multifocal+leukoencephalopathy%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Progressive multifocal leukoencephalopathy. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1176/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/000674.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1530,"resourceId":2161,"resourceName":"National Institute of Neurological Disorders and Stroke (NINDS)","descriptionText":"The <a href='http://www.ninds.nih.gov/disorders/pml/pml.htm' target='_blank'>National Institute of Neurological Disorders and Stroke</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/343475-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1532,"resourceId":2163,"resourceName":"Social Security Administration","descriptionText":"The <a href='https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022490' target='_blank'>Social Security Administration</a> has included this condition in their Compassionate Allowances Initiative. This initiative speeds up the processing of disability claims for applicants with certain medical conditions that cause severe disability. More information about <a href=\"http://www.ssa.gov/compassionateallowances/index.htm\" target=\"_blank\">Compassionate Allowances</a> and <a href=\"https://www.ssa.gov/benefits/disability/\" target=\"_blank\">applying for Social Security disability</a> is available online.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:643' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":4143,"questionText":"What is progressive multifocal leukoencephalopathy?","answerText":"<strong>Progressive multifocal leukoencephalopathy</strong> (PML) is a neurological disorder that damages the <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002261.htm\" target=_blank><font color=#005988>myelin</font></a> that covers and protects nerves in the <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002344.htm\" target=_blank><font color=#005988>white matter of the brain</font></a>. It is caused by the JC virus (JCV). By age 10, most people have been infected with this virus, but it&nbsp;rarely&nbsp;causes symptoms unless the immune system becomes severely weakened.[3100][3101]&nbsp;The disease occurs, rarely, in organ transplant patients; people undergoing chronic corticosteroid or immunosuppressive therapy; and individuals with cancer, such as Hodgkinâ€™s disease, lymphoma, and sarcoidosis.&nbsp; PML is most common among individuals with acquired immune deficiency syndrome (AIDS).[3102] ","dateModified":"2011-04-01T13:43:00"},"basicQuestions":[{"questionId":4145,"questionText":"What is the prognosis for individuals diagnosed with progressive multifocal leukoencephalopathy (PML)?","answerText":"The mortality rates for those with HIV-PML have fallen dramatically from approximately 90 percent to around 50 percent according to most reports.&nbsp;For non-AIDS individuals with PML, the prognosis remains grim; the disease usually lasts for months and 80 percent die within the first 6 months, although spontaneous improvement has been reported.&nbsp; Those who survive PML can be left with severe neurological disabilities.[3102] ","dateModified":"2011-03-03T22:36:00","resourceClassificationName":"Prognosis","references":[{"referenceId":3102,"authors":"","articleTitle":"NINDS Progressive Multifocal Leukoencephalopathy Information Page","bookWebsiteJournalTitle":"National Institute of Neurological Disorders and Stroke (NINDS)","date":"2010","url":"http://www.ninds.nih.gov/disorders/pml/pml.htm","dateAccessed":"2011-03-03T00:00:00"}]},{"questionId":4144,"questionText":"How might progressive multifocal leukoencephalopathy (PML) be treated?","answerText":"Currently, the best available therapy is reversal of the immune-deficient state. This can sometimes be accomplished by alteration of chemotherapy or immunosuppression. In the case of HIV-associated PML, immediately beginning anti-retroviral therapy will benefit most individuals.[3102]","dateModified":"2011-03-03T22:36:00","resourceClassificationName":"Treatment","references":[{"referenceId":3102,"authors":"","articleTitle":"NINDS Progressive Multifocal Leukoencephalopathy Information Page","bookWebsiteJournalTitle":"National Institute of Neurological Disorders and Stroke (NINDS)","date":"2010","url":"http://www.ninds.nih.gov/disorders/pml/pml.htm","dateAccessed":"2011-03-03T00:00:00"}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":12052,"relatedDiseaseName":"Demyelinating disease of central nervous system","relation":"Parent","isRare":false,"hasGardPage":false}],"gardCases":[],"news":[{"newsId":653,"dateCreated":"2019-04-24T13:58:00","publishDate":"2019-04-24T00:00:00","title":"Releasing an Immune System Brake Could Help Patients with Rare but Fatal Brain Infection","description":"The anti-cancer drug pembrolizumab has shown promise in slowing or stopping the progression of progressive multifocal leukoencephalopathy (PML), a typically fatal infection of the brain caused by the JC virus (JCV). This finding comes from a small-scale study by scientists at National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health. The study appears in the New England Journal of Medicine.","url":"https://www.nih.gov/news-events/news-releases/releasing-immune-system-brake-could-help-patients-rare-fatal-brain-infection","lastModified":"2019-04-24T13:59:00","isFeatured":false},{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Progressive_multifocal_leukoencephalopathy"}